Solid Biosciences, LLC
SEC CIK 1707502 · SLDB · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2020 - 2026 |
| RA Capital Management, LLC | Director | filed 2020 - 2026 |
| Kolchinsky Peter | Director | filed 2020 - 2026 |
| Shah Rajeev M. | Director | filed 2018 - 2026 |
| Edelman Joseph | Director | filed 2018 - 2026 |
| Smith IAN F | Director | filed 2020 - 2026 |
| Perceptive Advisors LLC | Director | filed 2018 - 2026 |
| Perceptive Life Sciences Master Fund LTD | Director | filed 2018 - 2026 |
| Nagendran Sukumar | Director | filed 2018 - 2026 |
| Freed Martin I | Director | filed 2018 - 2026 |
| Stone Adam Leo | Director | filed 2018 - 2026 |
| Ganot Ilan | Director · Chief Executive Officer | filed 2018 - 2026 |
| Sullivan Lynne Marie | Director | filed 2018 - 2026 |
| Keresty Georgia | Director | filed 2021 - 2026 |
| Kahn Clare | Director | filed 2021 - 2026 |
| Cumbo Alexander | Director · President and CEO | filed 2022 - 2026 |
| Bcip Life Sciences Associates, LP | Director | filed 2022 - 2025 |
| Bain Capital Life Sciences Partners, LP | Director | filed 2022 - 2025 |
| Bain Capital Life Sciences Investors, LLC | Director | filed 2022 - 2025 |
| Bcls SB Investco, LP | Director | filed 2022 - 2025 |
| Perceptive Xontogeny Venture Fund, LP | Director | filed 2022 - 2025 |
| Bain Capital Life Sciences Fund II, L.P. | Director | filed 2022 - 2025 |
| Bain Capital Life Sciences Investors II, LLC | Director | filed 2022 - 2025 |
| Bcls II Equity Opportunities, LP | Director | filed 2024 - 2025 |
| Bcls II Investco, LP | Director | filed 2022 - 2025 |
| Bcls II Investo (GP), LLC | Director | filed 2022 - 2025 |
| Bcls II Equity Opportunities GP, LLC | Director | filed 2024 - 2025 |
| Koppel Adam | Director | filed 2018 - 2024 |
| RA Capital Nexus Fund, L.P. | Director | filed 2022 - 2024 |
| Huffines Robert Luther | Director | filed 2018 - 2022 |
| Perceptive Venture Advisors, LLC | Director | filed 2022 - 2022 |
| Arnold Matthew Bennett | Director | filed 2018 - 2020 |
| Zarur Juan Andrey | Director | filed 2018 - 2020 |
| Hayeem Gilad David | Director · President | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Howton David T | See Remarks | filed 2022 - 2026 |
| Tan Kevin | CFO & Treasurer | filed 2023 - 2026 |
| Hanrahan Jessie | Chief Regulatory Officer | filed 2022 - 2026 |
| Herzich Paul | Chief Technology Officer | filed 2022 - 2026 |
| Brooks Gabriel | Chief Medical Officer | filed 2023 - 2026 |
| Marlowe Jennifer | CSO, FA & Cardiac | filed 2022 - 2024 |
| Morris Carl Ashley | Chief Scientific Officer | filed 2018 - 2023 |
| Brennan Erin Powers | Chief Legal Officer, Secretary | filed 2021 - 2022 |
| Schneider Joel Solomon Zev | See Remarks | filed 2018 - 2022 |
| Dipalma Stephen J. | Interim CFO | filed 2021 - 2021 |
| Ziolkowski Jennifer Lynn | See Remarks | filed 2018 - 2021 |
| Herscha Lynette | See Remarks | filed 2019 - 2020 |
| Quiroz Jorge Armando | Chief Medical Officer | filed 2018 - 2019 |
| Amorrortu Pedro Alvaro | Chief Operating Officer | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.